Who owns Emergent BioSolutions?
Emergent BioSolutions
- Brand origin
- United States
- Main production
- United States
Emergent BioSolutions is a publicly traded specialty biopharmaceutical company (NYSE: EBS) focused on providing preparedness and response solutions for public health threats, including chemical, biological, and opioid-related emergencies.
Ownership data is compiled from public sources and verified where possible. Spotted an error? Suggest a correction below.
Products from Emergent BioSolutions
1Alternatives to Emergent BioSolutions
Brands in the same category that are not American-owned:
- See all products from Teva
Teva
Teva Pharmaceutical Industries Ltd. · Israel
- See all products from Sandoz
Sandoz
Sandoz Group AG · Switzerland
- See all products from Cinfa
Cinfa
Infarco, S.A. · Spain
- See all products from Ratiopharm
Ratiopharm
Teva Pharmaceutical Industries Ltd. · Israel
- See all products from EG (EuroGenerici)
EG (EuroGenerici)
STADA Arzneimittel AG · Germany
- See all products from 1 A Pharma
1 A Pharma
Sandoz Group AG · Switzerland

